COMMUNIQUÉS West-GlobeNewswire

U.S. FDA Accepts Shire's Biologics License Application for Calaspargase Pegol (Cal-PEG) for Acute Lymphoblastic Leukemia (ALL)

28/02/2018 - 08:00

U.S. FDA Accepts Shire's Biologics License Application for Calaspargase Pegol (Cal-PEG) for Acute Lymphoblastic Leukemia (ALL) If approved, Cal-PEG could provide a new PEGylated asparaginase first-line treatment for [...]

On “Grindeks” results in 2017

28/02/2018 - 07:56

Today, on 28 February, the JSC “Grindeks” submitted the non-audited consolidated financial statements of 2017 to “Nasdaq Riga”. Non-audited financial results indicate that in 2017 turnover of the Group was 132.4 million [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

28/02/2018 - 07:06

REGULATED INFORMATION GHENT, Belgium, 28 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

ABLYNX ANNOUNCES CONVERSION OF BONDS

28/02/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 28 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced that in relation to the €100,000,000, 3.25% Senior Unsecured Convertible Bonds due on 27 May 2020 ( [...]

MDxHealth contract SelectMDx with Roman Hospital

28/02/2018 - 07:01

NEWS RELEASE MDxHealth enters into commercial agreement for SelectMDx with Fondazione Luigi Maria Monti - Istituto Dermopatico dell' Immacolata Hospital in Rome HERSTAL, BELGIUM and IRVINE, CA - 07:00 CEST, February 28 [...]

COMMUNIQUE DE PRESSE MDxHealth Contrat Commercial

28/02/2018 - 07:01

COMMUNIQUÉ DE PRESSE MDxHealth conclut un contrat commercial avec Fondazione Luigi Maria Monti - Istituto Dermopatico dell' Immacolata Hospital à Rome pour la vente du test SelectMDx HERSTAL, BELGIQUE et IRVINE, CA - 07 [...]

UPDATE- Adventist Health Selects Michelle Fuentes to Lead Adventist Health Sonora

28/02/2018 - 02:42

ROSEVILLE, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii—today announced the appointment [...]

AnGes Announces First Patient Treated with NF-kappa B Decoy in Phase Ib Study to Treat Discogenic Low Back Pain

28/02/2018 - 01:31

TOKYO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- AnGes, Inc., a biopharmaceutical company focused on developing innovative gene-based medicines for serious diseases, announced today the treatment of the first patient with NF- [...]

Revive Therapeutics Announces Results for the Three and Six Months Ended December 31, 2017

28/02/2018 - 01:00

TORONTO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel [...]

Endocyte Announces Proposed Public Offering of Common Stock

28/02/2018 - 00:49

WEST LAFAYETTE, Ind., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, announced today that it intends to [...]

Important progress on pharmacare cannot be delayed by more studies: CFNU

28/02/2018 - 00:08

OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Canada’s nurses applaud the announcement in today’s federal budget of an Advisory Council on the Implementation of National Pharmacare, chaired by Dr. Eric Hoskins, with a [...]

Radient Technologies Inc. Releases Q3 2018 Results

28/02/2018 - 00:00

EDMONTON, Alberta , Feb. 27, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the "Company") (TSX Venture:RTI) announced today that it has released its third quarter financial results for the fiscal year [...]

BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China

28/02/2018 - 00:00

BEIJING, China, and CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]

R1 RCM to Release Fourth Quarter 2017 Results on March 9

27/02/2018 - 23:00

CHICAGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release [...]

Amedisys Reports Fourth Quarter and Year End 2017 Financial Results

27/02/2018 - 23:00

BATON ROUGE, La., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ) today reported its financial results for the three month period and year ended December 31, 2017. Three Month Periods Ended December 31 [...]

Mesoblast Operational Highlights and Financial Results for the Half-Year Ended December 31, 2017

27/02/2018 - 22:47

MELBOURNE, Australia and NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) today provided the market with an update on its operational highlights and consolidated financial results [...]

Burcon Announces Receipt of Nasdaq Letter Regarding Deficiency in Compliance With Certain Listing Rules

27/02/2018 - 22:40

VANCOUVER, British Columbia, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation [...]

Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results

27/02/2018 - 22:32

SAN DIEGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three [...]

Lexicon Pharmaceuticals to Present at Upcoming Investor Conferences

27/02/2018 - 22:30

THE WOODLANDS, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ) today announced that Jeffrey L. Wade, J.D., Executive Vice President, Corporate and Administrative Affairs and Chief [...]